CRISPR

MIT researchers have dramatically lowered the error rate of prime editing, a technique that holds potential for treating many genetic disorders

In preclinical models, the CRISPR-Cas9 gene therapy precisely repaired the genetic error that causes a rare vascular disease

Patient-derived xenograft systems serve as an essential approach for studying tumor progression, treatment response, and resistance over time

The bright, new future of therapeutic epigenome editing is already on our doorstep

USC Viterbi biomedical engineers harness focused ultrasound to revolutionize CRISPR’s capabilities to treat countless diseases

A new interdisciplinary project at Lehigh University aims to leverage AI and advanced modeling to refine CRISPR gene editing, enhancing safety and expanding its medical applications

With the new technique, researchers hope to identify mutations that could be targeted with new cancer therapies

Integrated single-cell approach to cellular genetic screening uncovers mechanisms driving cancer and autoimmunity

The FDA granted the approval of Casgevy to Vertex Pharmaceuticals Inc., and Lyfgenia to Bluebird Bio Inc.

How do T-cell receptors on the cell surface alert the nucleus far inside the cell of trouble?